GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cubist Pharmaceuticals, Inc. (CBST) [hlAlert]

Rating:
Buy CBST
up 466.55 %

Cubist Pharmaceuticals, Inc. (CBST) rated Buy with price target $42 by Needham

Posted on: Thursday,  Oct 20, 2011  8:25 AM ET by Needham

Needham rated Buy Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) on 10/20/2011. Previously Needham rated Buy Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) on 07/01/2008.,
when the stock price was $17.88. Since then, Cubist Pharmaceuticals, Inc. has gained 466.55% as of 01/16/2015's recent price of $101.30.
If you would have followed the previous Needham's recommendation on CBST, you would have gained 466.55% of your investment in 2390 days.

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN, the first antibiotic in a new class of antiinfectives called lipopeptides. The Cubist product pipeline includes our lipopeptide program and our natural products screening program. Cubist is headquartered in Lexington, MA.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/20/2011 8:25 AM Buy
None
39.42 42.00
as of 12/30/2011
1 Week down  -0.25 %
1 Month up  2.72 %
3 Months up  12.17 %
1 YTD up  85.14 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/15/2011 8:25 AM Buy
None
36.33 39.00
7/1/2008 9:25 AM Buy
None
17.88 24.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy